Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Seung Soo Hong

Matched on ORCID iD 0000-0001-9913-8437; OpenAlex author ID A5053733191. Sources: OpenAlex.

Their work

Papers
13 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 4 papers · 2026: 4 papers

Papers 13

  1. Feasibility and safety of minimally invasive distal pancreatosplenectomy in resectable and borderline resectable pancreatic cancer following neoadjuvant chemot… Co-author DOI 10.1007/s00464-025-12533-3↗
  2. Long-term oncologic outcomes and prognostic factors in resected stage IA pancreatic cancer: a retrospective cohort study. Co-author DOI 10.1007/s00464-026-12646-3↗
  3. Prospective Evaluation of Irreversible Electroporation With Clustered Electrodes as a Novel Palliative Approach for Locally Advanced Pancreatic Cancer. Co-author DOI 10.3348/kjr.2025.1394↗
  4. Development of an artificial intelligence-based prediction platform for early recurrence of resectable pancreatic cancer after curative surgery-toward future u… Co-author DOI 10.4174/astr.2026.110.2.76↗
  5. Perioperative Clinical Usage of Phellinus Linteus as a Nutraceutical for Non-FOLFIRINOX-Based Postoperative Adjuvant Chemotherapy for Resected Pancreatic Cance… First author DOI 10.1177/15347354251353499↗
  6. Optimal Number of Lymph Nodes Retrieved to Lower the Risk of False N0 for Patients with Pancreatic Cancer Undergoing Curative Surgery. First author DOI 10.1245/s10434-025-18029-7↗
  7. Is There a Potential Oncologic Role for Local Therapy on Hepatic Metastasis in Patients Who Undergo Curative Pancreatectomy for Pancreatic Cancer? First author DOI 10.3349/ymj.2024.0078↗
  8. Immediate Postoperative AbnobaVISCUM® F as an Adjuvant Treatment in Patients Receiving Standard Care after Pancreatic Cancer Resection. Co-author DOI 10.3349/ymj.2024.0493↗
  9. Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma-Cohort Study. Co-author DOI 10.3390/cancers16101844↗
  10. Anticancer effect of locally applicable aptamer-conjugated gemcitabine-loaded atelocollagen patch in pancreatic cancer patient-derived xenograft models. Co-author DOI 10.1111/cas.15318↗
  11. Neoadjuvant FOLFIRINOX Followed by Pancreatoduodenectomy for Pancreatic Cancer in Patients with Previous Transhiatal Esophagectomy for Esophageal Cancer. First author DOI 10.1159/000525294↗
  12. Laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer in patients with radical subtotal gastrectomy for gastric cancer. First author DOI 10.14701/ahbps.22-016↗
  13. Feasibility and Safety of Laparoscopic Radical Distal Pancreatosplenectomy with Adrenalectomy in Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-020-08670-9↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ho Kyoung Hwang · 12 shared papers, 2020–2026 · strength 3.39
  2. Chang Moo Kang · 11 shared papers, 2020–2026 · strength 2.80
  3. Sung Hyun Kim · 8 shared papers, 2022–2026 · strength 2.54
  4. So Jeong Yoon · 2 shared papers, 2025–2026 · strength 0.53
  5. Jin Seok Heo · 2 shared papers, 2025–2026 · strength 0.53
  6. In Woong Han · 2 shared papers, 2025–2026 · strength 0.53
  7. Hongbeom Kim · 2 shared papers, 2025–2026 · strength 0.53
  8. Sang Hyun Shin · 2 shared papers, 2025–2026 · strength 0.53
  9. Woo Jung Lee · 3 shared papers, 2020–2022 · strength 0.51
  10. Juwan Kim · 2 shared papers, 2022–2025 · strength 0.49
  11. In Soo Cho · 1 shared paper, 2026 · strength 0.39
  12. Jun Hyung Kim · 1 shared paper, 2025 · strength 0.33
  13. Seoung Yoon Rho · 1 shared paper, 2025 · strength 0.30
  14. Munseok Choi · 1 shared paper, 2025 · strength 0.30
  15. Su Hyeong Park · 1 shared paper, 2024 · strength 0.26
  16. Man Deuk Kim · 1 shared paper, 2026 · strength 0.24
  17. Moon Jae Chung · 1 shared paper, 2026 · strength 0.24
  18. Joon Ho Kwon · 1 shared paper, 2026 · strength 0.24
  19. Tae Yang Choi · 1 shared paper, 2026 · strength 0.24
  20. Seungmin Bang · 1 shared paper, 2026 · strength 0.24
  21. Seung‐seob Kim · 1 shared paper, 2022 · strength 0.19
  22. Kang Hee Lee · 1 shared paper, 2022 · strength 0.19
  23. Choong‐kun Lee · 1 shared paper, 2022 · strength 0.16
  24. Sung Hwan Lee · 1 shared paper, 2022 · strength 0.16
  25. Jung Hwan Lee · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.